InMed Pharmaceuticals (NASDAQ: INM) announced an amendment to its previously disclosed all-stock merger agreement with privately held Mentari Therapeutics, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE